Cancer Research UK
Giving over time
| Month | Given | Impact band | Activities logged |
|---|---|---|---|
| Dec 2025 | $0 | Not rated | 0 |
| Jan 2026 | $0 | Not rated | 0 |
| Feb 2026 | $0 | Limited | 1 |
| Mar 2026 | $0 | Not rated | 0 |
| Apr 2026 | $0 | Substantial | 1 |
| May 2026 | $0 | Moderate | 1 |
| Jun 2026 | $0 | Transformative | 1 |
| Jul 2026 | $0 | Moderate | 1 |
| Aug 2026 | $0 | Not rated | 0 |
| Sep 2026 | $0 | Moderate | 1 |
| Oct 2026 | $0 | Not rated | 0 |
| Nov 2026 | $0 | Not rated | 0 |
Cause breakdown
About
Cancer Research UK is the world's largest cancer charity and is focused on preventing, diagnosing and treating cancer through research and innovation. Founded in 2002 through the merger of the Cancer Research Campaign and Imperial Cancer Research Fund, the organization funds research into more than 200 types of cancer and works to improve cancer outcomes across the UK.
Its work includes funding scientific and clinical research, providing trusted cancer information, supporting policy and prevention campaigns, and developing partnerships to accelerate new tests and treatments. Cancer Research UK also operates a large retail network and fundraising programs that generate income to support its research and other activities.
Activity feed
Board
Independent member of the House of Lords and former Chief Executive of NHS England, currently Chair of the UK Maritime and Coastguard Agency and Chair of Council of King's College London.
Emeritus Professor of Clinical Paediatric Oncology at the University of Birmingham and former Director of its Cancer Research UK Clinical Trials Unit.
Former Partner of Carlyle, the global alternative asset management company, and a past Chairman of the British Venture Capital Association.
Professor of Cellular Immunology at the University of Dundee, researching the molecular mechanisms that control lymphocyte function.
Professor of Cancer Biology at King's College London and Principal Group Leader at the Francis Crick Institute, researching the molecular biology of cancer.
Executive-level marketer with 29 years of experience across Direct Line Group, HSBC and Mars, and founder of the Sprintathon fundraising event for Stand Up To Cancer.
Emeritus Professor at the University of Manchester and former Director of the Manchester Cancer Research Centre, having also served as CRUK Chief Scientist.
Global Chief Data Officer for Chubb Insurance, with prior data leadership roles at Santander, NHS England and HSBC.
Chief Scientific Officer of the Princess Maxima Centre for Paediatric Oncology, researching mechanisms that protect genomic integrity in cancer.
Former President and Vice-Chancellor of the University of Manchester and a neuroscientist known for research on brain damage in stroke and head injury.
Deputy Chair of Vitality UK and Chair of Trustees at the Royal College of Paediatrics and Child Health, with a background in NHS and public sector governance.
Senior Partner and Global Leader of Technology and AI at McKinsey & Company, and co-author of the WSJ-bestseller Rewired.
Partner at Syncona venture fund and Chair of the Health Innovation Network AHSN for South London, with two decades of experience in global public equities.
Chartered accountant with over 35 years of experience in corporate finance and real estate, currently Senior Independent Director of Bellway plc.